BYBEE CLINTON

CIK 000121904339 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001219043

Recent Transactions

50 trades

Purchase
Neumora Therapeutics, Inc.$NMRA
Common Stock
2025-10-27$2.61/sh+1,915,700→ 6,046,907 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+1,048,433→ 1,048,433 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+589,743→ 617,092 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−454,212→ 0 total
Purchase
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02$16.00/sh+133,333→ 1,181,766 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−424,908→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series C Convertible Preferred Stock
2024-04-02−366,301→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series B Convertible Preferred Stock
2024-04-02−227,920→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series C Convertible Preferred Stock
2024-04-02−164,835→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series A Convertible Preferred Stock
2024-04-02−586,080→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Series C Convertible Preferred Stock
2024-04-02−201,465→ 0 total
Conversion
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02+787,545→ 828,570 total
Purchase
Boundless Bio, Inc.$BOLD
Common Stock
2024-04-02$16.00/sh+66,667→ 683,759 total
Purchase
Sana Biotechnology, Inc.$SANA
Common Stock
2024-02-08$5.50/sh+727,272→ 12,446,022 total
Purchase
Sana Biotechnology, Inc.$SANA
Common Stock
2024-02-08$5.50/sh+727,272→ 12,446,022 total
Purchase
Sana Biotechnology, Inc.$SANA
Common Stock
2024-02-08$5.50/sh+363,637→ 10,667,387 total
Other
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-12-08+1,176,593→ 2,321,566 total
Other
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-12-08+703,061→ 1,387,228 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-1 Preferred Stock
2023-09-19−1,144,973→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-2 Preferred Stock
2023-09-19−6,576,400→ 0 total
Purchase
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19$17.00/sh+1,500,000→ 3,624,143 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+684,167→ 684,167 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series B Preferred Stock
2023-09-19−2,124,143→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+2,124,143→ 2,124,143 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+1,144,973→ 1,144,973 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+6,576,400→ 11,886,758 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-1 Preferred Stock
2023-09-19−684,167→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Series A-2 Preferred Stock
2023-09-19−6,895,021→ 0 total
Conversion
Neumora Therapeutics, Inc.$NMRA
Common Stock
2023-09-19+6,895,021→ 12,205,379 total
Purchase
Codiak BioSciences, Inc.
Warrant (Right to Buy)
2022-09-13+5,000,000→ 5,000,000 total
Purchase
Codiak BioSciences, Inc.
Common Sotck
2022-09-13$1.50/sh+5,000,000→ 8,854,098 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-06−310,441→ 7,290,655 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-06−239,559→ 5,626,008 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-06+3,248→ 61,160 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-06+1,624→ 30,570 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-06+14,383→ 272,964 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-02+11,763→ 258,581 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-02+2,662→ 57,912 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-02−196,003→ 5,865,567 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-02+1,338→ 28,946 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-09-02−253,997→ 7,601,096 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-31+1,475→ 27,608 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-31+13,076→ 246,818 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-31−282,219→ 7,855,093 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-31−217,781→ 6,061,570 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-31+2,952→ 55,250 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-30−217,781→ 6,279,351 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-30+2,952→ 52,298 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-30+1,475→ 26,133 total
Other
Vir Biotechnology, Inc.$VIR
Common Stock
2022-08-30+13,076→ 233,742 total

Companies

Recent Filings

Address

8725 WEST HIGGINS ROAD, SUITE 290

CHICAGO, IL, 60631

View on SEC.gov